$5.11 Billion is the total value of Eventide Asset Management's 142 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 48.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| W | Buy | WAYFAIR INCcl a | $167,675,000 | +48.1% | 576,184 | +0.6% | 3.28% | +33.4% |
| TTD | Buy | THE TRADE DESK INC | $156,404,000 | +28.3% | 301,484 | +0.5% | 3.06% | +15.5% |
| FIVN | Buy | FIVE9 INC | $150,304,000 | +18.0% | 1,159,035 | +0.7% | 2.94% | +6.2% |
| CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $136,583,000 | +38.0% | 994,635 | +0.8% | 2.67% | +24.3% |
| DT | Buy | DYNATRACE INC | $108,500,000 | +44.5% | 2,645,050 | +43.0% | 2.12% | +30.1% |
| ROP | Buy | ROPER TECHNOLOGIES INC | $100,042,000 | +10.9% | 253,200 | +9.0% | 1.96% | -0.2% |
| TWLO | Buy | TWILIO INCcl a | $95,870,000 | +13.2% | 387,997 | +0.5% | 1.88% | +2.0% |
| POOL | Buy | POOL CORP | $83,568,000 | +23.3% | 249,800 | +0.2% | 1.64% | +11.1% |
| IDXX | Buy | IDEXX LABS INC | $79,015,000 | +36.0% | 201,000 | +14.2% | 1.55% | +22.5% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $76,455,000 | +18.5% | 1,275,100 | +1.4% | 1.50% | +6.8% |
| FVRR | Buy | FIVERR INTL LTD | $71,838,000 | +144.3% | 516,893 | +29.8% | 1.41% | +120.0% |
| TT | Buy | TRANE TECHNOLOGIES PLC | $71,538,000 | +70.3% | 590,000 | +25.0% | 1.40% | +53.3% |
| HUBS | Buy | HUBSPOT INC | $68,870,000 | +32.3% | 235,672 | +1.6% | 1.35% | +19.2% |
| LRCX | Buy | LAM RESEARCH CORP | $66,949,000 | +3.0% | 201,806 | +0.4% | 1.31% | -7.2% |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $64,516,000 | +22.6% | 356,600 | +15.0% | 1.26% | +10.4% |
| TREX | Buy | TREX CO INC | $63,151,000 | +29.8% | 882,000 | +135.8% | 1.24% | +16.9% |
| VRSK | Buy | VERISK ANALYTICS INC | $61,782,000 | +65.4% | 333,400 | +51.9% | 1.21% | +48.9% |
| ANNX | New | ANNEXON INC | $52,395,000 | – | 1,773,111 | +100.0% | 1.03% | – |
| IPHI | Buy | INPHI CORP | $51,004,000 | -3.5% | 454,378 | +1.0% | 1.00% | -13.1% |
| ECL | New | ECOLAB INC | $45,963,000 | – | 230,000 | +100.0% | 0.90% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $45,429,000 | +120.5% | 3,197,008 | +25.5% | 0.89% | +98.4% | |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $45,171,000 | +2.5% | 271,300 | +3.0% | 0.88% | -7.7% |
| ZI | New | ZOOMINFO TECHNOLOGIES INC | $44,882,000 | – | 1,044,018 | +100.0% | 0.88% | – |
| CTAS | New | CINTAS CORP | $44,266,000 | – | 133,000 | +100.0% | 0.87% | – |
| RNG | Buy | RINGCENTRAL INCcl a | $43,759,000 | -0.9% | 159,349 | +2.8% | 0.86% | -10.7% |
| SPT | New | SPROUT SOCIAL INC | $37,730,000 | – | 980,007 | +100.0% | 0.74% | – |
| MGA | Buy | MAGNA INTL INC | $36,284,000 | +10.9% | 793,100 | +7.9% | 0.71% | -0.1% |
| FRLN | New | FREELINE THERAPEUTICS HLDGSsponsored ads added | $35,620,000 | – | 2,343,304 | +100.0% | 0.70% | – |
| PANW | Buy | PALO ALTO NETWORKS INC | $35,563,000 | +9.2% | 145,302 | +2.4% | 0.70% | -1.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $34,637,000 | -20.7% | 360,200 | +0.7% | 0.68% | -28.6% |
| DDOG | Buy | DATADOG INC | $34,258,000 | +19.8% | 335,335 | +1.9% | 0.67% | +7.9% |
| IMVT | Buy | IMMUNOVANT INC | $32,797,000 | +115.2% | 932,000 | +48.9% | 0.64% | +94.0% |
| NOVT | Buy | NOVANTA INC | $29,758,000 | -0.5% | 282,492 | +0.9% | 0.58% | -10.3% |
| SWKS | Buy | SKYWORKS SOLUTIONS INC | $22,986,000 | +21.3% | 157,977 | +6.6% | 0.45% | +9.2% |
| MDB | Buy | MONGODB INCcl a | $20,326,000 | +4.4% | 87,797 | +2.1% | 0.40% | -5.9% |
| MPWR | New | MONOLITHIC PWR SYS INC | $19,845,000 | – | 70,975 | +100.0% | 0.39% | – |
| ADCT | Buy | ADC THERAPEUTICS SA | $19,150,000 | +172.8% | 580,483 | +287.0% | 0.38% | +145.1% |
| NRIX | New | NURIX THERAPEUTICS INC | $17,376,000 | – | 497,740 | +100.0% | 0.34% | – |
| ETNB | Buy | 89BIO INC | $17,321,000 | +51.1% | 675,000 | +17.4% | 0.34% | +36.1% |
| BEPC | New | BROOKFIELD RENEWABLE CORPcl a sub vtg added | $16,712,000 | – | 285,200 | +100.0% | 0.33% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $16,276,000 | +61.6% | 297,000 | +69.7% | 0.32% | +45.7% |
| JAMF | New | JAMF HLDG CORP | $16,172,000 | – | 430,000 | +100.0% | 0.32% | – |
| EIDX | Buy | EIDOS THERAPEUTICS INC | $16,039,000 | +58.0% | 317,417 | +49.0% | 0.31% | +42.1% |
| EPIX | Buy | ESSA PHARMA INC | $15,307,000 | +29.3% | 2,335,169 | +16.2% | 0.30% | +16.7% |
| CHMA | Buy | CHIASMA INC | $12,901,000 | +148.8% | 3,000,326 | +211.2% | 0.25% | +123.9% |
| KURA | New | KURA ONCOLOGY INC | $12,256,000 | – | 400,000 | +100.0% | 0.24% | – |
| MKC | Buy | MCCORMICK & CO INC | $12,151,000 | +12.9% | 62,600 | +4.3% | 0.24% | +1.7% |
| RLAY | New | RELAY THERAPEUTICS INC | $10,648,000 | – | 250,000 | +100.0% | 0.21% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $10,320,000 | +41.4% | 699,200 | +42.0% | 0.20% | +27.0% |
| IMTX | New | IMMATICS N.V | $8,488,000 | – | 800,000 | +100.0% | 0.17% | – |
| PLD | Buy | PROLOGIS INC. | $7,697,000 | +63.0% | 76,500 | +51.2% | 0.15% | +46.6% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $7,507,000 | +24.6% | 506,179 | +9.2% | 0.15% | +12.2% |
| A | Buy | AGILENT TECHNOLOGIES INC | $7,409,000 | +28.2% | 73,400 | +12.2% | 0.14% | +15.1% |
| ITT | Buy | ITT INC | $5,982,000 | +63.7% | 101,300 | +62.9% | 0.12% | +48.1% |
| ARE | Buy | ALEXANDRIA REAL ESTATE EQ IN | $5,936,000 | +10.2% | 37,100 | +11.7% | 0.12% | -0.9% |
| STE | Buy | STERIS PLC | $5,145,000 | +74.6% | 29,200 | +52.1% | 0.10% | +57.8% |
| ENTG | Buy | ENTEGRIS INC | $4,391,000 | +420.3% | 59,061 | +313.0% | 0.09% | +377.8% |
| KLAC | Buy | KLA CORP | $4,335,000 | +66.3% | 22,374 | +67.0% | 0.08% | +49.1% |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $4,275,000 | +25.3% | 39,200 | +21.7% | 0.08% | +13.5% |
| JKHY | Buy | HENRY JACK & ASSOC INC | $4,309,000 | -3.6% | 26,500 | +9.1% | 0.08% | -13.4% |
| AWK | Buy | AMERICAN WATER WORKS CO INC | $4,187,000 | +29.7% | 28,900 | +15.1% | 0.08% | +17.1% |
| CWEN | New | CLEARWAY ENERGY INCcl c | $4,047,000 | – | 150,100 | +100.0% | 0.08% | – |
| SHW | Buy | SHERWIN WILLIAMS CO | $3,762,000 | +32.9% | 5,400 | +10.2% | 0.07% | +19.4% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $3,785,000 | +49.6% | 27,800 | +31.1% | 0.07% | +34.5% |
| AMWL | New | AMERICAN WELL CORPcl a added | $3,263,000 | – | 110,091 | +100.0% | 0.06% | – |
| Buy | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $2,963,000 | +63.0% | 2,139,000 | +96.8% | 0.06% | +45.0% | |
| ZTS | Buy | ZOETIS INCcl a | $2,911,000 | +49.6% | 17,600 | +23.9% | 0.06% | +35.7% |
| SYY | New | SYSCO CORP | $2,296,000 | – | 36,900 | +100.0% | 0.04% | – |
| SNPS | New | SYNOPSYS INC | $1,977,000 | – | 9,238 | +100.0% | 0.04% | – |
| DPZ | New | DOMINOS PIZZA INC | $1,999,000 | – | 4,700 | +100.0% | 0.04% | – |
| IEX | Buy | IDEX CORP | $2,007,000 | +71.7% | 11,000 | +48.6% | 0.04% | +56.0% |
| MSCI | Buy | MSCI INC | $1,606,000 | +33.6% | 4,500 | +25.0% | 0.03% | +19.2% |
| TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $1,475,000 | – | 18,200 | +100.0% | 0.03% | – |
| IMTXW | New | IMMATICS N.V*w exp 07/01/202 added | $1,380,000 | – | 400,000 | +100.0% | 0.03% | – |
| LSCC | New | LATTICE SEMICONDUCTOR CORP | $700,000 | – | 24,169 | +100.0% | 0.01% | – |
| OM | New | OUTSET MED INC | $682,000 | – | 13,636 | +100.0% | 0.01% | – |
| DOCU | New | DOCUSIGN INC | $630,000 | – | 2,925 | +100.0% | 0.01% | – |
| SLAB | New | SILICON LABORATORIES INC | $427,000 | – | 4,368 | +100.0% | 0.01% | – |
| AMD | New | ADVANCED MICRO DEVICES INC | $337,000 | – | 4,108 | +100.0% | 0.01% | – |
| OSH | New | OAK STR HEALTH INC | $267,000 | – | 5,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.